-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
June 11, 2019 - 10.1001/jama.2019.2591
Editorial page 2172
Author Audio Interview
Related article page 2203 and
JAMA Patient … 4
What is the diagnostic accuracy of provider or patient risk assessment tools in identifying individuals … Sourcea Country
Duration of
Follow-up Interventionsb
HIV Risk Group;
Risk-Based Inclusion
Criteria Patient … Sourcea Country
Duration of
Follow-up Interventionsb
HIV Risk Group;
Risk-Based Inclusion
Criteria Patient … b Daily, oral dose unless specified.
c Sample of patient who reported that they were taking PrEP.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/bF_Y9vcT3eNPdHjTxPZsUZ
April 17, 2023 - In an existing systematic review of older adults,
14 included trials did not report safety data.1,58 … Key Substance Use and Mental
Health Indicators in the United States: Results From
the 2018 National … Prevalence of Selected Maternal and Child
Health Indicators for All PRAMS Sites, Pregnancy
Risk Assessment … https://www.cdc.gov/prams/prams-data/mch-
indicators/states/pdf/2019/All-Sites_PRAMS_
Prevalence-of-Selected-Indicators … Ethnicity and diagnosis in patients with affective
disorders.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-KMSTWRT9xbm7spaqDq_GE
February 12, 2019 - Efficacy and Safety of Screening for
Postpartum Depression. … outcomes from a randomized
controlled trial to prevent perinatal depression in
low-income home visiting clients … Preventing perinatal depression in
low-income home visiting clients: a randomized
controlled trial. … Screening for depression in adult patients in
primary care settings: a systematic evidence
review. … Safety of selective serotonin reuptake inhibitors
in pregnancy: a review of current evidence.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/CW23r2jqogvTG2_-kBjRxH
January 01, 2007 - Loss of dental enamel in a
patient taking cholestyramine. … Increased AST and ALT (1% of
patients). … All resolved
with patient continuing
medication.
Transient decreased HCT. … Serum folate decreased in all patients.
Table 4. … Endurance running performance in relation to cardiovascular risk indicators in adolescents.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/99YKN27_cW9CRosq9RUMnv
March 11, 2025 - Viewpoint and Editorial
Multimedia
Related articles and JAMA
Patient Page
Supplemental content
CME … Clinicians should understand the evidence but individualize
decision-making to the specific patient or … food insecurity, housing instability, transporta-
tion problems, utility help needs, and interpersonal safety … For example, a clinician may
identify a patient with food insecurity, but if the patient or clinician … Development of indicators to assess hunger.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening
August 21, 2018 - Clinicians should understand the evidence but individualize decision making to the specific patient or … Safety of extending screening intervals beyond five years in cervical screening programmes with testing … Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical … Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening … https://www.aafp.org/patient-care/clinical-recommendations/all/cervical-cancer.html . 2018.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/RrE4_peSk5zVH3cCf77at3
June 24, 2025 - Editorial
Related article and JAMA
Patient Page
Supplemental content
CME at jamacmelookup.com
Related … : 5
Median, 24
Range NR
94
(mothers)
NR
Ernst et al,22 2004
Fair
OVAT Current English-speaking patients … Patients of eligible physicians were mailed a survey
regarding participant and screening for fear of … Second,
this review did not evaluate clinician or patient preferences for
how screening is implemented … Clinical utility of an intimate
partner violence screening tool for female VHA
patients.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nonpregnant-adolescents-and-adults1/human-immunodeficiency-virus-hiv-infection-screening
June 11, 2019 - Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine … in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. … Real-world assessment of renal and bone safety among patients with HIV infection exposed to tenofovir … Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/cervical-cancer-screening
August 21, 2018 - Clinicians should understand the evidence but individualize decision making to the specific patient or … Safety of extending screening intervals beyond five years in cervical screening programmes with testing … Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical … Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening … https://www.aafp.org/patient-care/clinical-recommendations/all/cervical-cancer.html . 2018.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/SUHq3jffCaucDobFXKewQ_
February 01, 2013 - Inves-
tigators created an analytic framework incorporating the
key questions and outlining the patient … Mean injury
score (CIS)
Self-reported
spanking (FSS,
CIS)
Self-reported
neglect (FSS)
Mean home
safety … Conflict Tactics Scale; ED �
emergency department; FSC � Kempe Family Stress Checklist; FSS � Framingham Safety … nurse practitioners in 18 private
practices in mostly suburban areas with primarily white,
middle-class patients … Provision of study materials or patients: H.D. Nelson.
Statistical expertise: H.D. Nelson.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
November 01, 2014 - Clinicians should
understand the evidence but individualize decision making to
the specific patient or … CLINICAL CONSIDERATIONS
Patient Population Under Consideration
This recommendation applies to adults … Safety of stenting and endarterectomy by symptomatic
status in the Carotid Revascularization Endarterectomy … Accessed at www
.aafp.org/patient-care/clinical-recommendations/cps.html on 10 June 2014. … professional
judgment and patient preferences.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-october-2018
October 23, 2018 - Clinical utility of an intimate partner violence screening tool for female VHA patients. … Safety-promoting behaviors of community-dwelling abused Chinese women after an advocacy intervention: … questions, and received information about referral options
Women with a positive response to safety … If questions indicated a safety concern, the emergency department provider was notified and a referral … g Five-item unnamed screener designed to assess relationship quality and safety using nongraphic language
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/q_zxLD9JZFGoSPCrEHNk2g
June 11, 2019 - Editorial
Author Audio Interview
Related articles and JAMA
Patient Page
Supplemental content
Related … the key questions that the review will
address to allow the USPSTF to evaluate the effectiveness and safety … Durable efficacy and
safety of raltegravir versus efavirenz when
combined with tenofovir/emtricitabine … Real-world
assessment of renal and bone safety among
patients with HIV infection exposed to tenofovir … Comparative safety and neuropsychiatric adverse
events associated with efavirenz use in first-line
antiretroviral
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
April 01, 2013 - How to select patients for these medi-
cations in clinical practice has not been clear, however, and … Three studies reported the concordance of physicians’
recommendations and their patients’ medication … Safety and adverse
effects associated with raloxifene: multiple outcomes of raloxifene evaluation. … Safety assess-
ment of raloxifene over eight years in a clinical trial setting. … Provision of study materials or patients: H.D. Nelson.
Statistical expertise: H.D. Nelson, R. Fu.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
April 15, 2013 - How to select patients for these medications in clinical practice has not been clear, however, and use … Three studies reported the concordance of physicians' recommendations and their patients' medication … Measures of adherence and persistence in clinical trials may not be similar for patients in clinical … Safety assessment of raloxifene over eight years in a clinical trial setting. … Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary13/child-maltreatment-primary-care-interventions-2013
January 15, 2013 - Investigators created an analytic framework incorporating the key questions and outlining the patient … assessment was conducted using the Parent Screening Questionnaire, a 20-item, self-report questionnaire of safety … nurse practitioners in 18 private practices in mostly suburban areas with primarily white, middle-class patients … CTS) Mean injury score (CIS) Self-reported spanking (FSS, CIS) Self-reported neglect (FSS) Mean home safety … Conflict Tactics Scale; ED = emergency department; FSC = Kempe Family Stress Checklist; FSS = Framingham Safety
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary39/obesity-in-children-and-adolescents-screening-2010
January 15, 2010 - In the Maahs et al trial, 36 1 suicide death of a patient who was under a psychiatrist's care occurred … Note that 9% of orlistat patients reported fecal incontinence, compared with <1% of patients on placebo … been conducted among children aged ≤11 years, so no conclusions can be drawn regarding efficacy or safety … We found no data on maintenance of treatment effect or safety after the 6 to 12 months of active treatment … for childhood overweight and obesity. 30 These KQs were designed to evaluate the effectiveness and safety
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/U7JR2xtrb6EHFyLP6yUTAK
March 20, 2018 - professional judgment and patient preferences. … Potential Harms
Skin self-examination is performed by the patient and is noninva-
sive. … tanning.10
The Environmental Protection Agency provides a variety of
educational tools regarding sun safety … It also
provides sun safety fact sheets and handouts, including age-
appropriate materials.11
Figure … Sun
safety. https://www.epa.gov/sunsafety. Accessed
February 2, 2018.
12.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults
June 20, 2023 - In an existing systematic review of older adults, 14 included trials did not report safety data. 1 , … screened, referred, and treated for depression, as well as patient health outcomes. … Key Substance Use and Mental Health Indicators in the United States: Results From the 2018 National Survey … Prevalence of Selected Maternal and Child Health Indicators for All PRAMS Sites, Pregnancy Risk Assessment … https://www.cdc.gov/prams/prams-data/mch-indicators/states/pdf/2019/All-Sites_PRAMS_Prevalence-of-Selected-Indicators
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/njteJ388DLVsY8RLcBTe_A
February 25, 2020 - planning, including advance directives;
safety planning; legal and financial planning); patient health … Efficacy,
safety and tolerability of rivastigmine capsules in
patients with probable vascular dementia … The efficacy and safety of donepezil in
patients with Alzheimer’s disease: results of a US
multicentre … Efficacy
and safety of rivastigmine in patients with
Alzheimer’s disease: international randomised
controlled … Efficacy and
safety of galantamine in patients with mild to
moderate Alzheimer’s disease: multicentre